Kakyung Kim

Archives
Log in
Subscribe
October 9, 2026

๐Ÿ“ˆ econ-radar 2026-10-09 ยท ์ค‘๋ฆฝ๊ธˆ๋ฆฌ(r*)์™€ ๊ณ ๊ธˆ๋ฆฌ ๋‰ด๋…ธ๋ฉ€: ์ธํ”Œ๋ ˆ์ด์…˜ ์žฌ์ ํ™” vs. ์—ฐ์ฐฉ๋ฅ™ ๋ถ„๊ธฐ์ 

๐Ÿ“ˆ econ-radar 2026-10-09 ยท ์ค‘๋ฆฝ๊ธˆ๋ฆฌ(r*)์™€ ๊ณ ๊ธˆ๋ฆฌ ๋‰ด๋…ธ๋ฉ€: ์ธํ”Œ๋ ˆ์ด์…˜ ์žฌ์ ํ™” vs. ์—ฐ์ฐฉ๋ฅ™ ๋ถ„๊ธฐ์ 

๐Ÿ“ˆ econ-radar ๋ฐ์ผ๋ฆฌ

2026-10-09

์ œ์•ฝยท๋ฐ”์ด์˜คยทAI์— ๋ฌด๊ฒŒ๋ฅผ ๋‘” ๊ฒฝ์ œ ๋ฐ์ผ๋ฆฌ โ€” ์‚ฐ์—…๊ตฌ์กฐยทํˆฌ์žยท์‹œ์žฅ 3๋ Œ์ฆˆ

At a Glance

๐Ÿ’ฐ ๋ฏธ 10๋…„๋ฌผ์ด 2002๋…„ ์ดํ›„ ์ฒ˜์Œ์œผ๋กœ 5.35%๋ฅผ ๋ŒํŒŒํ–ˆ๊ณ , ์ด๋ž€ ํ˜ธ๋ฅด๋ฌด์ฆˆ ๋ด‰์‡„ ์žฌ๊ฐœ๋กœ Brent $100์ด ๊ฒน์น˜๋ฉด์„œ 10/14 CPI๊ฐ€ ์ธํ”Œ๋ ˆ์ด์…˜ ๊ฒฝ๋กœ๋ฅผ ๊ฐ€๋ฅด๋Š” ๊ฒฐ์ •์  ๋ฐ์ดํ„ฐ๊ฐ€ ๋๋‹ค.

๐Ÿญ ํ•œ๋ฏธ์•ฝํ’ˆ์ด ๊ตญ์‚ฐ GLP-1 ์ตœ์ดˆ ํ—ˆ๊ฐ€๋ฅผ ๋ฐ›๊ณ  ๋‚ด์ผ B7-H3 ADC PDUFA๊ฐ€ ๋งž๋ฌผ๋ฆฌ๋ฉด์„œ, ๊ตญ๋‚ด์™ธ ๋ฐ”์ด์˜ค ๊ตฌ๋„ ๋ณ€ํ™”๊ฐ€ ์ดํ‹€์— ์••์ถ•๋๋‹ค.

๐Ÿš€ Anthropic IPO๊ฐ€ 11์›”๋กœ ๋ฐ€๋ฆฐ ์‚ฌ์ด ๋‘ ๋ฐ”์ด์˜คํ…์ด ์˜ค๋Š˜ ๋‚˜์Šค๋‹ฅ์— ์ƒ์žฅํ•ด, ๊ณ ๊ธˆ๋ฆฌ 5.35% ํ™˜๊ฒฝ์—์„œ IPO ์ฐฝ๊ตฌ๊ฐ€ ์–ด๋””๊นŒ์ง€ ์—ด๋ ค ์žˆ๋Š”์ง€๋ฅผ ์‹œํ—˜ํ–ˆ๋‹ค. ์˜ค๋Š˜์€ ํ•œ๊ธ€๋‚  ๊ณตํœด์ผ๋กœ ์ฝ”์Šคํ”ผยท์ฝ”์Šค๋‹ฅ์€ ํœด์žฅ์ด๋‹ค.

Today's Top 5

Macro

1. ๋ฏธ 10๋…„๋ฌผ ๊ตญ์ฑ„ 5.35% ๋ŒํŒŒ โ€” 2002๋…„ ์ดํ›„ 24๋…„ ๋งŒ์˜ ์ตœ๊ณ 

10์›” 7์ผ ๋ฏธ๊ตญ 10๋…„๋ฌผ ๊ตญ์ฑ„ ์ˆ˜์ต๋ฅ ์ด 5.35%๋ฅผ ๋„˜์–ด์„œ๋ฉฐ 2002๋…„ 4์›” ์ดํ›„ ๊ฐ€์žฅ ๋†’์€ ์ˆ˜์ค€์— ๋„๋‹ฌํ–ˆ๋‹ค. 30๋…„๋ฌผ๋„ 24๋…„ ๋งŒ์˜ ์ตœ๊ณ ์น˜๋ฅผ ๊ธฐ๋กํ–ˆ๊ณ , ๋‹ฌ๋Ÿฌ ์ธ๋ฑ์Šค(DXY)๋Š” 18๊ฐœ์›” ๋งŒ์˜ ๊ณ ์  102.50์— ์•ˆ์ฐฉํ–ˆ๋‹ค.

โ†— FXStreet DXYยทYield 10/7

Macro

2. Brent ์›์œ  $100 ์žฌ์ง„์ž… โ€” ์ด๋ž€ ํ˜ธ๋ฅด๋ฌด์ฆˆ ํ•ดํ˜‘ ๋ด‰์‡„ ์žฌ๊ฐœ

์ด๋ž€์ด 10์›” 7์ผ ํ˜ธ๋ฅด๋ฌด์ฆˆ ํ•ดํ˜‘ ์œ ์กฐ์„  ๊ณต๊ฒฉ์„ ์žฌ๊ฐœํ•˜๋ฉด์„œ Brent ์„ ๋ฌผ์ด $100๋ฅผ ์žฌ๋ŒํŒŒํ–ˆ๋‹ค. ํ•ดํ˜‘ ํ†ต๊ณผ ์ˆœ์ˆ˜์ถœ์ด ์ •์ƒ ๋Œ€๋น„ ์•ฝ 30% ๊ฐ์†Œํ•œ ์ƒํƒœ์—์„œ ์ด๋ž€์€ ํ™”๋ฌผ ๊ฐ€์น˜์˜ 5~7%์— ํ•ด๋‹นํ•˜๋Š” ํ†ตํ–‰๋ฃŒ๋ฅผ ์š”๊ตฌํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ํ˜‘์ƒ์€ ๊ต์ฐฉ ์ƒํƒœ์— ๋น ์ง„ ๊ฒƒ์œผ๋กœ ๋ณด๋„๋๋‹ค.

โ†— FXStreet Brent/Iran 10/7

Bio

3. ifinatamab deruxtecan PDUFA D-1 โ€” ๋‚ด์ผ(10/10) FDA ๊ฒฐ์ •

Daiichi SankyoยทMerck ๊ณต๋™ ๊ฐœ๋ฐœ ํ•ญ์ฒด์•ฝ๋ฌผ์ ‘ํ•ฉ์ฒด(ADC, Antibody-Drug Conjugate) ifinatamab deruxtecan(I-DXd)์˜ ๋ฏธ๊ตญ FDA PDUFA ๋ชฉํ‘œ์ผ์ด ๋‚ด์ผ(10์›” 10์ผ)์ด๋‹ค. 10์›” 9์ผ ๊ธฐ์ค€ FDA์˜ ์„ ์ œ์  ๊ฒฐ์ •(์กฐ๊ธฐ ์Šน์ธยท์™„์ „์‘๋‹ต์„œํ•œ(CRL))์€ ๊ณต๊ฐœ ์ฑ„๋„์—์„œ ํ™•์ธ๋˜์ง€ ์•Š์•˜๋‹ค. ํ—ˆ๊ฐ€ ๊ทผ๊ฑฐ๋Š” Phase 2 IDeate-Lung01์˜ ๊ฐ๊ด€์ ๋ฐ˜์‘๋ฅ (ORR) 48.2%(137๋ช…)์ด๋ฉฐ, ์‹ค์‹œ๊ฐ„์ข…์–‘ํ•™์‹ฌ์‚ฌ(Real-Time Oncology Review)์™€ ๊ตญ์ œ๊ณต๋™์‹ฌ์‚ฌ(Project Orbis)๊ฐ€ ์ ์šฉ๋๋‹ค.

โ†— CureToday I-DXd FDA Oct 10

Bio

4. ํ•œ๋ฏธ์•ฝํ’ˆ efpeglenatide ์‹์•ฝ์ฒ˜ ์Šน์ธ โ€” ๊ตญ๋‚ด ์ตœ์ดˆ ์ฃผ 1ํšŒ GLP-1 ๋น„๋งŒ์น˜๋ฃŒ์ œ

ํ•œ๋ฏธ์•ฝํ’ˆ์ด 10์›” 7์ผ ์‹ํ’ˆ์˜์•ฝํ’ˆ์•ˆ์ „์ฒ˜(MFDS)๋กœ๋ถ€ํ„ฐ ๋น„๋งŒ์น˜๋ฃŒ์ œ efpeglenatide(์—ํ”„ํŽ˜๊ธ€๋ ˆ๋‚˜ํƒ€์ด๋“œ) ํ—ˆ๊ฐ€๋ฅผ ๋ฐ›์•˜๋‹ค. ์‚ฌ๋…ธํ”ผ(Sanofi)์™€์˜ ๊ธ€๋กœ๋ฒŒ 3์ƒ(AMPLITUDE ์‹œ๋ฆฌ์ฆˆ) ๊ณต๋™ ๊ฐœ๋ฐœ ํ›„ ์‚ฌ๋…ธํ”ผ๊ฐ€ 2020๋…„ ๊ธ€๋กœ๋ฒŒ ๊ถŒ๋ฆฌ๋ฅผ ๋ฐ˜ํ™˜ํ•ด ํ•œ๋ฏธ์•ฝํ’ˆ์ด ๊ตญ๋‚ดยท์ผ๋ถ€ ์•„์‹œ์•„ ์‹œ์žฅ ๊ถŒ๋ฆฌ๋ฅผ ๋‹จ๋… ๋ณด์œ ํ•œ ์ž์‚ฐ์ด๋‹ค.

โ†— StockHub.kr

AIMarket

5. Anthropic IPO 11์›” 9์ผ ์ฃผ๋กœ ์—ฐ๊ธฐ โ€” 10์›” 25์ผ S-1 ๊ณต๊ฐœ๊ฐ€ ์ฒซ ์ฒดํฌํฌ์ธํŠธ

๋ชจํ‹€๋ฆฌํ’€(Motley Fool)์ด 10์›” 6์ผ Anthropic์˜ ๋‚˜์Šค๋‹ฅ IPO ๋กœ๋“œ์‡ผ๊ฐ€ 11์›” 9์ผ ์ฃผ๊ฐ„์— ์‹œ์ž‘๋  ์ˆ˜ ์žˆ๋‹ค๊ณ  ๋ณด๋„ํ–ˆ๋‹ค. 11์›” 3์ผ ๋ฏธ ์ค‘๊ฐ„์„ ๊ฑฐ ์ดํ›„ ๋กœ๋“œ์‡ผ๋ฅผ ์ง„ํ–‰ํ•˜๋Š” ๋ฐฉํ–ฅ์„ ๊ฒ€ํ†  ์ค‘์ธ ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์กŒ๋‹ค. 6์›” 1์ผ ๋น„๋ฐ€ S-1์„ SEC์— ์ œ์ถœํ–ˆ์œผ๋‚˜ 10์›” 9์ผ ๊ธฐ์ค€ ๊ณต๊ฐœ S-1์€ EDGAR์— ๋“ฑ๋ก๋˜์ง€ ์•Š์€ ์ƒํƒœ๋‹ค.

โ†— CNN Anthropic IPO (10/5)

๐Ÿ—ฃ ์˜ค๋Š˜์˜ ํ™”์ œ

r* ์ƒํ–ฅ ๊ตฌ์กฐํ™”๋กœ ์žฅ๊ธฐ ๊ธˆ๋ฆฌ ํ”ผํฌ๊ฐ€ ์˜ˆ์ƒ๋ณด๋‹ค ๋†’์•„์กŒ๊ณ , 10/14 CPI๊ฐ€ ์ธํ”Œ๋ ˆ์ด์…˜ ์žฌ์ ํ™” ์—ฌ๋ถ€๋ฅผ ํ™•์ธํ•˜๊ฑฐ๋‚˜ ๋ฐ˜๋ฐ•ํ•  ์ฒซ ๋ฒˆ์งธ ๋ฐ์ดํ„ฐ๋‹ค.

์ „์ฒด ๋ฆฌํฌํŠธ ๋ณด๊ธฐ โ†’

Deep Dive ยท Demand ยท Investment ยท Companies ยท Sources ์ „์ฒด๋Š” ์œ„ ๋งํฌ์—์„œ ๋ณด์‹ค ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

ํ…”๋ ˆ๊ทธ๋žจ @econradar ๋กœ๋„ ๋ฐ›๊ธฐ

econ-radar ยท 2026-10-09

ํˆฌ์ž ์ฐธ๊ณ ์šฉ ์ •๋ณด์ž…๋‹ˆ๋‹ค. ์ตœ์ข… ํŒ๋‹จ๊ณผ ์ฑ…์ž„์€ ๋ณธ์ธ์—๊ฒŒ ์žˆ์Šต๋‹ˆ๋‹ค.

Don't miss what's next. Subscribe to Kakyung Kim:
โ† Newer ๐Ÿ“ˆ econ-radar 2026-10-10 ยท FDA ๊ฐ€์†์Šน์ธ(Accelerated Approval) Older โ†’ ๐Ÿ“ˆ econ-radar 2026-10-08 ยท ์‚ผ์„ฑ์ „์ž 107์กฐ, AI ๋ฐ˜๋„์ฒด ๋ฐธ๋ฅ˜์ฒด์ธ์˜ ์ฒซ ๋ฒˆ์งธ ์ˆ˜ํ™• ์‚ฌ์ดํด
Powered by Buttondown, the easiest way to start and grow your newsletter.